Bellevue Funds (Lux) Bellevue Healthcare Strategy I2 Fonds
222,14
EUR
+1,49
EUR
+0,68
%
NAV
Werbung
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Vertex Pharmaceuticals Inc | US92532F1003 | 3,40% |
| Eli Lilly and Co | US5324571083 | 3,33% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 3,24% |
| UnitedHealth Group Inc | US91324P1021 | 3,20% |
| HCA Healthcare Inc | US40412C1018 | 3,15% |
| Insulet Corp | US45784P1012 | 3,14% |
| McKesson Corp | US58155Q1031 | 3,12% |
| IQVIA Holdings Inc | US46266C1053 | 2,99% |
| Boston Scientific Corp | US1011371077 | 2,96% |
| UCB SA | BE0003739530 | 2,83% |
| Sonstige | 68,64% |